GLW Medical Innovation
  • Medical Device Development
  • News
  • Investing
  • Our Portfolio
  • Contact
  • Login
    • GLW Fund I
    • Altior
    • Carbon22
    • Carta

News

October 31, 2022

Altior Trauma Announces FDA 510(K) Clearance for the Artemis Proximal Femoral Nail System

NEW LONG NAIL TO STRENGTHEN THE ARTEMIS SYSTEM AND STREAMLINE WORKFLOWS ENGLEWOOD CLIFFS, NJ, USA, October 31, 2022 /...

March 13, 2022

Carbon22 Receives FDA 510(k) Clearance for Apollo™ Ankle Fracture Plating System

Englewood Cliffs, NJ., — Carbon22™, a GLW, Inc. medical technology company with a focus on the foot and ankle orthopedic...

May 23, 2021

Solvay and Carbon22™ partner on Creed™ Cannulated Screws for orthopedics

Alpharetta, Ga., — Solvay’s Zeniva® polyetheretherketone (PEEK) resin was chosen by Carbon22™, a GLW, Inc. company, for its new Creed™ Cannulated Screw...

February 22, 2021

Altior Trauma Announces FDA 510(K) Clearance for the Artemis Proximal Femoral Nail System

A FOURTH-GENERATION HIP FRACTURE NAIL MANUFACTURED USING A REVOLUTIONARY PROCESS ENGLEWOOD CLIFFS, NJ, USA, February 22, 2021 / –...

December 17, 2020

Carbon22 Receives FDA 510(k) Clearance for the Creed™ Cannulated Screw System

ENGLEWOOD CLIFFS, NJ, USA, December 17, 2020 — Carbon22™, a GLW, Inc. company, announced today that it has received...

September 29, 2020

Carbon22 Receives FDA 510(k) Clearance for FusionFrame™ Ring Lock System

Carbon22 Consortium designed circular external fixator can treat complex foot and ankle deformities as well as provide a static...

  • About us
  • News
  • Medical Device Development
  • Investing
  • Our Portfolio

This website may contain forward-looking statements within the meaning of the relevant sections of the Securities Act. Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate, or imply future results, performance or achievements, and may contain the words “estimate,” “project,” “intend,” “forecast,” “anticipate,” “plan,” “planning,” “expect,” “believe,” “will,” “will likely,” “should,” “could,” “would,” “may” or words or expressions of similar meaning. All such forward-looking statements and statements of expectations, plans and intent are subject to a number of risks and uncertainties. GLW, Inc. actual future results may differ materially or adversely from those described in the forward-looking statements as a result of, among other things, uncertainties and other matters described in this website, generally. GLW, Inc. undertakes no obligation to release the results of any revisions to these forward-looking statements that may be made to reflect any future events or circumstances. GLW, Inc. cautions the reader, however, that the identified uncertainties and other cautionary language contained herein may not be exhaustive. Nothing in this website shall be construed to be an offer to sell or a solicitation of an offer to purchase any particular securities. Any such offer or solicitation will be made only pursuant to definitive legal agreements prepared specifically for such purpose.

Copyright © 2023 GLW Medical Innovation